Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children

Todd Nebesio, Aslam R. Siddiqui, Ora H. Pescovitz, Erica Eugster

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Objective: To characterize the development of hypothyroidism in pediatric patients who receive a fixed dose of radioactive iodine (RAI). Study design: Medical records of children treated with fixed-dose RAI for Graves' disease between 1993 and 2001 were reviewed. Multiple variables including sex, age, thyroid hormone levels, thyroid-stimulating immunoglobulin titer, antithyroid medication use, and 24-hour radioiodine uptake were investigated as possible predictive factors for the development of hypothyroidism after treatment. All patients received RAI at a dose of between 13.8 and 15.6 mCi (average, 14.7 mCi; SD, 0.5). Results: Permanent hypothyroidism developed in all 40 patients, although a second dose of RAI was required in one case. The average time to hypothyroidism was 77 days (SD, 52), with a range of 28 to 194 days; 75% of the patients were diagnosed with hypothyroidism between 40 and 90 days. RAI treatment was ineffective in an additional patient, who required subtotal thyroidectomy. Conclusions: We conclude that a fixed dose of RAI is effective therapy in nearly all pediatric patients with Graves' disease. Factors predicting the time course to hypothyroidism were not identified.

Original languageEnglish
Pages (from-to)99-103
Number of pages5
JournalJournal of Pediatrics
Volume141
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Graves Disease
Hypothyroidism
Iodine
Therapeutics
Thyroid-Stimulating Immunoglobulins
Pediatrics
Thyroidectomy
Thyroid Hormones
Medical Records

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. / Nebesio, Todd; Siddiqui, Aslam R.; Pescovitz, Ora H.; Eugster, Erica.

In: Journal of Pediatrics, Vol. 141, No. 1, 2002, p. 99-103.

Research output: Contribution to journalArticle

@article{f0a602c91647464bb265654aab9380d7,
title = "Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children",
abstract = "Objective: To characterize the development of hypothyroidism in pediatric patients who receive a fixed dose of radioactive iodine (RAI). Study design: Medical records of children treated with fixed-dose RAI for Graves' disease between 1993 and 2001 were reviewed. Multiple variables including sex, age, thyroid hormone levels, thyroid-stimulating immunoglobulin titer, antithyroid medication use, and 24-hour radioiodine uptake were investigated as possible predictive factors for the development of hypothyroidism after treatment. All patients received RAI at a dose of between 13.8 and 15.6 mCi (average, 14.7 mCi; SD, 0.5). Results: Permanent hypothyroidism developed in all 40 patients, although a second dose of RAI was required in one case. The average time to hypothyroidism was 77 days (SD, 52), with a range of 28 to 194 days; 75{\%} of the patients were diagnosed with hypothyroidism between 40 and 90 days. RAI treatment was ineffective in an additional patient, who required subtotal thyroidectomy. Conclusions: We conclude that a fixed dose of RAI is effective therapy in nearly all pediatric patients with Graves' disease. Factors predicting the time course to hypothyroidism were not identified.",
author = "Todd Nebesio and Siddiqui, {Aslam R.} and Pescovitz, {Ora H.} and Erica Eugster",
year = "2002",
doi = "10.1067/mpd.2002.125494",
language = "English",
volume = "141",
pages = "99--103",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children

AU - Nebesio, Todd

AU - Siddiqui, Aslam R.

AU - Pescovitz, Ora H.

AU - Eugster, Erica

PY - 2002

Y1 - 2002

N2 - Objective: To characterize the development of hypothyroidism in pediatric patients who receive a fixed dose of radioactive iodine (RAI). Study design: Medical records of children treated with fixed-dose RAI for Graves' disease between 1993 and 2001 were reviewed. Multiple variables including sex, age, thyroid hormone levels, thyroid-stimulating immunoglobulin titer, antithyroid medication use, and 24-hour radioiodine uptake were investigated as possible predictive factors for the development of hypothyroidism after treatment. All patients received RAI at a dose of between 13.8 and 15.6 mCi (average, 14.7 mCi; SD, 0.5). Results: Permanent hypothyroidism developed in all 40 patients, although a second dose of RAI was required in one case. The average time to hypothyroidism was 77 days (SD, 52), with a range of 28 to 194 days; 75% of the patients were diagnosed with hypothyroidism between 40 and 90 days. RAI treatment was ineffective in an additional patient, who required subtotal thyroidectomy. Conclusions: We conclude that a fixed dose of RAI is effective therapy in nearly all pediatric patients with Graves' disease. Factors predicting the time course to hypothyroidism were not identified.

AB - Objective: To characterize the development of hypothyroidism in pediatric patients who receive a fixed dose of radioactive iodine (RAI). Study design: Medical records of children treated with fixed-dose RAI for Graves' disease between 1993 and 2001 were reviewed. Multiple variables including sex, age, thyroid hormone levels, thyroid-stimulating immunoglobulin titer, antithyroid medication use, and 24-hour radioiodine uptake were investigated as possible predictive factors for the development of hypothyroidism after treatment. All patients received RAI at a dose of between 13.8 and 15.6 mCi (average, 14.7 mCi; SD, 0.5). Results: Permanent hypothyroidism developed in all 40 patients, although a second dose of RAI was required in one case. The average time to hypothyroidism was 77 days (SD, 52), with a range of 28 to 194 days; 75% of the patients were diagnosed with hypothyroidism between 40 and 90 days. RAI treatment was ineffective in an additional patient, who required subtotal thyroidectomy. Conclusions: We conclude that a fixed dose of RAI is effective therapy in nearly all pediatric patients with Graves' disease. Factors predicting the time course to hypothyroidism were not identified.

UR - http://www.scopus.com/inward/record.url?scp=0036065453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036065453&partnerID=8YFLogxK

U2 - 10.1067/mpd.2002.125494

DO - 10.1067/mpd.2002.125494

M3 - Article

VL - 141

SP - 99

EP - 103

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -